Zimmer Biomet HoldingsXSWX:ZBH 65 Days Inventory is 361.16 as of Mar. 2026, which is 5% below its 10-year median of 380.44. GuruFocus rates XSWX:ZBH with a GF Score™ of 65/100 and a GF Value™ of CHF102.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Zimmer Biomet Holdings ranks worse than 82.19% on this metric.
The historical rank and industry rank for Zimmer Biomet Holdings's Days Inventory or its related term are showing as below:
XSWX:ZBH'
s Days Inventory Range Over the Past 10 Years
Min: 322.85 Med: 380.44 Max: 483.76
Current: 339.36
During the past 13 years, Zimmer Biomet Holdings's highest Days Inventory was 483.76. The lowest was 322.85. And the median was 380.44.
XSWX:ZBH's Days Inventory is ranked worse than 82.19% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs XSWX:ZBH: 339.36
Zimmer Biomet Holdings's Days Inventory
declined
from Mar. 2025 (373.41) to Mar. 2026 (361.16).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zimmer Biomet Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.25.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zimmer Biomet Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.09.
Zimmer Biomet Holdings (XSWX:ZBH) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zimmer Biomet Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zimmer Biomet Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zimmer Biomet Holdings Days Inventory Related Terms
Zimmer Biomet Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for Zimmer Biomet Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:ZBH vs STE, PEN, GMED: Days Inventory Comparison
For the Medical Devices subindustry, Zimmer Biomet Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings (XSWX:ZBH) has a Days Inventory of 361.16 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zimmer Biomet Holdings and its competitors. This is near median its historical median of 380.44. Over the past decade, Zimmer Biomet Holdings' Days Inventory has ranged from 322.85 to 483.76. According to the industry distribution chart, Zimmer Biomet Holdings ranks #646 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 82.2%.
Is Zimmer Biomet Holdings' Days Inventory too high?
Zimmer Biomet Holdings' current Days Inventory of 361.16 is near median its 10-year median of 380.44. Over the past 10 years, this metric has ranged from a low of 322.85 to a high of 483.76. The Medical Devices & Instruments industry median Days Inventory is 179.60. Zimmer Biomet Holdings' value of 361.16 is 101.1% above this industry median. Based on the distribution chart, Zimmer Biomet Holdings ranks #646 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Zimmer Biomet Holdings has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Days Inventory compare to STE and PEN?
According to the Medical Devices & Instruments industry distribution chart, Zimmer Biomet Holdings ranks #646 out of 786 companies for Days Inventory. This places Zimmer Biomet Holdings in the lower half of its industry. The industry median Days Inventory is 179.60. Zimmer Biomet Holdings' value of 361.16 is 101.1% above this benchmark. Historically, Zimmer Biomet Holdings' own Days Inventory has ranged from 322.85 to 483.76 over the past decade. While the company's 10-year median is 380.44 vs. the industry median of 179.60, Zimmer Biomet Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zimmer Biomet Holdings's current Days Inventory of 361.16 is 101.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zimmer Biomet Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zimmer Biomet Holdings's current Days Inventory is 361.16, which is near median its own 10-year median of 380.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (XSWX:ZBH) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF102.97, compared to a current price of CHF74.50 — trading 27.6% below its estimated fair value. The current Days Inventory is 361.16, which is near median its 10-year median of 380.44 and 101.1% above the Medical Devices & Instruments industry median of 179.60. Zimmer Biomet Holdings' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Days Inventory is 361.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of CHF74.50 is trading 27.6% below its estimated GF Value™ of CHF102.97.
GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.
Key valuation signals for XSWX:ZBH:
Days Inventory: 361.16 (near median its 10-year median of 380.44)
GF Value™: CHF102.97 vs. price of CHF74.50 (27.6% below fair value)
Industry Position: 101.1% above the Medical Devices & Instruments median (#646 of 786)
No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
65GF Score
Get the complete analysis for XSWX:ZBH
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ZBH has been successfully added to your 
